Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICaRAS – Intravenous Iron for Cancer-Related Anaemia Symptoms (Feasibility Study)
2018-001669-17Phase 4Unknown
- Sponsor
- Nottingham University Hospitals
- Start
- Jun 2019
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of ferric derisomaltose in iron deficiency anemia (IDA) and anaemia, sponsored by Nottingham University Hospitals. Primary endpoint: Feasibility of study design. Status: unknown.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)anaemia
Beyond the preview
Go deeper on 2018-001669-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001669-17.